Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to $8.4 million.

  • Zai Lab's Gains from Investment Securities rose 44170.95% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 38291.89%. This contributed to the annual value of $15.2 million for FY2024, which is 7212.0% up from last year.
  • As of Q3 2025, Zai Lab's Gains from Investment Securities stood at $8.4 million, which was up 44170.95% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Zai Lab's Gains from Investment Securities peaked at $30.0 million during Q3 2021, and registered a low of -$1.4 million during Q1 2025.
  • Its 5-year average for Gains from Investment Securities is $4.5 million, with a median of $2.1 million in 2023.
  • In the last 5 years, Zai Lab's Gains from Investment Securities surged by 11500000.0% in 2022 and then tumbled by 15849.69% in 2025.
  • Zai Lab's Gains from Investment Securities (Quarter) stood at $30.0 million in 2021, then plummeted by 93.53% to $1.9 million in 2022, then tumbled by 96.03% to $77000.0 in 2023, then soared by 14451.95% to $11.2 million in 2024, then decreased by 24.77% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $1.2 million for Q2 2025, and -$1.4 million during Q1 2025.